8-K: Shuttle Pharma Pivots to Dogecoin Mining in Major Merger

Shuttle Pharmaceuticals Holdings, Inc. announced a definitive merger with United Dogecoin Inc. and an $11 million PIPE financing, aiming to become the largest publicly listed Dogecoin miner.

Summary

• Shuttle Pharmaceuticals Holdings, Inc. (Acquiror) has entered into a definitive merger agreement with United Dogecoin Inc. (Company), a Dogecoin mining company, which will result in United Dogecoin becoming a direct wholly-owned subsidiary of Acquiror.
• Existing United Dogecoin equity holders will receive 8,000 shares of a newly designated Series B-1 Convertible Preferred Stock of Acquiror, which will be convertible into approximately 32,258,064 shares of Acquiror Common Stock at an initial conversion price of $1.24 per share, subject to stockholder approval.
• Post-merger, existing United Dogecoin equity holders are expected to collectively hold 75.65% of the total issued and outstanding equity securities of Acquiror on an as-converted, fully diluted basis (excluding PIPE shares), or 68.85% assuming all Milestone Shares are issued.
• United Dogecoin equity holders are also entitled to receive up to 118,038,551 pre-funded warrants exercisable for Acquiror Common Stock upon the new wholly-owned subsidiary meeting certain operational milestones, subject to stockholder approval.
• A concurrent Private Investment in Public Equity (PIPE) financing of $11,000,000 was entered into with accredited investors, involving the issuance of 2,200 shares of newly designated Series B-2 Convertible Preferred Stock and Common Warrants.
• The Series B-2 Preferred Stock will be convertible into approximately 9,708,738 shares of Acquiror Common Stock at a conversion price of $1.03 per share, and the Common Warrants have an exercise price of $1.03 and a 3-year term, both subject to stockholder approval.
• PIPE investors will also receive up to 34,932,064 pre-funded warrants upon the post-merger company meeting operational milestones, subject to stockholder approval.
• The first $5,000,000 of gross proceeds from the PIPE will be deposited into accounts designated by Legacy Sub (Acquiror's existing business), with the remainder (after Transaction Expenses) going to the Surviving Corporation (United Dogecoin).
• E.F. Hutton & Co. served as the exclusive M&A advisor and placement agent, receiving 750 shares of Series B-1 Preferred Stock (convertible into 3,024,749 shares of Acquiror Common Stock) and Pre-Funded Warrants for 11,066,114 shares as advisor fees, plus an 8.0% cash fee and 1.00% non-accountable expense fee from the PIPE proceeds.
• An amendment to an existing Asset Purchase Agreement (dated November 20, 2025) was also executed, where the Seller (1542770 BC Ltd.) returned 320,496 shares of Parent Common Stock for cancellation.
• In exchange, the Seller will receive 270 shares of Series B-1 Convertible Preferred Stock and a cash payment of $3,646,642, along with contingent rights to up to 3,844,314 additional pre-funded warrants upon meeting specific Dogecoin mining rig and operational uptime milestones.
• The transactions are intended to qualify as a reorganization under Section 368(a) of the Code or an integrated tax-free exchange under Section 351(a).

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a high-risk, transformative transaction. While the pivot to Dogecoin mining offers potential upside in a niche market, the significant dilution for existing shareholders and the inherent volatility and regulatory uncertainty of the crypto sector warrant a cautious outlook.

Positives

• The merger represents a strategic pivot into the Dogecoin mining sector, which management believes is in its infancy and offers significant growth potential.
• United Dogecoin's management team, led by Ryan Trasolini, has a track record of success in building and scaling public cryptocurrency mining companies, including experience with Hut 8 and American Bitcoin.
• The company expects to secure preferential access to high-efficiency ElphaPex Mining Rigs and low-cost, behind-the-meter, renewable energy, which could provide a competitive advantage.
• The strategy includes holding mined Dogecoin on the balance sheet to build long-term asset value, a model that has proven successful in Bitcoin mining.
• The combined entity aims to become the largest publicly listed Dogecoin mining company based on percentage of global hashrate, with an expected 43,200 GH/s, representing approximately 1.5% of the world's Dogecoin mining capacity.

Negatives

• Existing Shuttle Pharmaceuticals shareholders face substantial dilution from the issuance of Series B-1 and B-2 Preferred Stock, Common Warrants, and Pre-Funded Warrants, which will result in United Dogecoin equity holders owning a significant majority of the combined entity.
• The company is undergoing a complete business model pivot from a pharmaceutical software AI platform to Dogecoin mining, introducing a new and potentially higher-risk profile for existing investors.
• The PIPE financing incurs substantial placement agent fees, including an 8.0% cash fee and a 1.00% non-accountable expense fee of the gross proceeds, reducing the net capital available for operations.
• The realization of significant warrant issuances and preferred stock conversions is contingent upon future stockholder approval, introducing uncertainty.

Risks

• The price of DOGE and other cryptocurrencies is highly volatile, which could significantly impact the company's financial performance and asset value.
• There is significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally, which could lead to adverse changes in the operating environment.
• The treatment of digital assets for U.S. and foreign tax purposes is complex and subject to change, potentially affecting profitability.
• The company's DOGE treasury strategy is unproven, and there is a risk that it may not generate the anticipated returns.
• Changes in Shuttle's capital structure and corporate governance following the merger could have adverse effects on the market value of its securities.
• The ability of Shuttle and the post-merger company to retain customers and key personnel, and maintain relationships with suppliers, is crucial and subject to risk.
• The merger could distract management from ongoing business operations or cause the company to incur substantial costs.
• There is a risk that Shuttle may be unable to reduce expenses or access necessary financing or liquidity in the future.
• The company is exposed to the impact of any related economic downturn.
• Changes in governmental regulations or enforcement practices related to cryptocurrency mining could adversely affect operations.

Future Outlook

The combined company aims to be a global leader in Dogecoin mining, leveraging high-efficiency, low-cost operations and a strategy of holding mined Dogecoin on its balance sheet to build long-term asset value. This strategy is intended to mirror successful Bitcoin mining approaches, positioning the company for growth in the nascent Dogecoin sector.

Management Comments

• "Through our size, relationships, expertise and timing, we believe that we are uniquely positioned to be a global leader in Dogecoin mining." Ryan Trasolini, CEO of United Dogecoin.
• "The completion of this transaction will give investors exposure to Dogecoin via our dual-pronged strategy of mining Dogecoin with highly efficient, cost-effective rigs and holding mined Dogecoin on our balance sheet to build long-term asset value." Ryan Trasolini.
• "This strategy has been successful in Bitcoin mining, and we are ready to apply it to Dogecoin mining with a view to deliver long-term shareholder value." Ryan Trasolini.
• "We believe that while the opportunity for incredible upside in new Bitcoin miners has passed, Dogecoin mining is in its infancy, and United Dogecoin is well positioned to be a leader in the space." Andrew Kiguel, CEO of Realbotix, co-founder of Hut 8 and United Dogecoin board member.

Industry Context

StockSavvy.ai notes that this merger represents a significant strategic pivot for Shuttle Pharmaceuticals into the nascent Dogecoin mining sector. The move capitalizes on the perceived 'infancy' of Dogecoin mining, contrasting it with the more mature Bitcoin mining space. The strategy of combining efficient mining operations with holding mined assets on the balance sheet is a proven model in Bitcoin mining, as exemplified by Hut 8, and its application to Dogecoin could position the combined entity as an early leader in this specific cryptocurrency niche.

Comparison to Industry Standards

• The company's strategy of combining efficient mining operations with holding mined assets on the balance sheet is explicitly compared to Hut 8 (NASDAQ: HUT), a successful Bitcoin mining company, leveraging a proven model.
• Ryan Trasolini's prior experience as a founding shareholder of US Bitcoin Corp (merged with Hut 8) and co-founder of American Data Centers (partnered with Hut 8 to create American Bitcoin, NASDAQ: ABTC) provides a direct link to established industry benchmarks and expertise in scaling crypto mining ventures.
• The target hash rate of 43,200 GH/s is stated to be approximately 1.5% of the world's Dogecoin mining capacity, providing a specific market share benchmark for the combined entity.
• The expected access to low-cost, behind-the-meter, renewable energy at a rate not exceeding $0.075 per kilowatt-hour is highlighted as a key competitive advantage, positioning the company favorably against industry energy cost benchmarks, which are critical for mining profitability.

Management Changes

Corporate Governance

Related Party Transactions

• E.F. Hutton & Co. (Placement Agent) will receive 750 shares of Series B-1 Preferred Stock (convertible into 3,024,749 shares of Acquiror Common Stock) and Pre-Funded Warrants to purchase up to 11,066,114 shares of Acquiror Common Stock as financial advisor fees for the merger.
• E.F. Hutton & Co. will receive a cash fee equal to 8.0% of the gross proceeds of the PIPE Financing, plus a non-accountable expenses fee of 1.00% of the aggregate gross proceeds, and certain reimbursable expenses, for its role as placement agent.
• The Second Amendment to Asset Purchase Agreement involves 1542770 BC Ltd. (Seller) and ZhiTian (Andy) Zhang (Seller Guarantor), who are receiving 270 shares of Series B-1 Convertible Preferred Stock and $3,646,642 in cash, and returning 320,496 shares of Parent Common Stock for cancellation. They are also entitled to contingent pre-funded warrants.

Stakeholder Impact

• Shareholders (Shuttle Pharmaceuticals): Will experience significant dilution, with United Dogecoin equity holders becoming majority owners. The company's business model will fundamentally shift from pharmaceutical software to Dogecoin mining, altering the investment risk profile.
• Shareholders (United Dogecoin): Will gain public market access and liquidity for their holdings, becoming the controlling shareholders of a Nasdaq-listed entity.
• Management: Ryan Trasolini (United Dogecoin CEO) will become Co-Chief Executive Officer of the combined company, indicating a new strategic direction and leadership focus on Dogecoin mining. Christopher Cooper will continue as Co-CEO, and Yuying Liang as CFO.
• Employees: Certain employees of United Dogecoin are expected to enter into employment agreements with the combined entity.
• Customers/Suppliers: United Dogecoin's expected preferential access to ElphaPex mining hardware and low-cost energy providers could benefit its operational efficiency and competitive standing in the Dogecoin mining market.

Next Steps

• Closing of the Merger and PIPE financing is expected on May 4, 2026.
• Acquiror will file a Certificate of Designations for Series B-1 and B-2 Preferred Stock immediately prior to Closing.
• Acquiror will file a Proxy Statement with the SEC to solicit stockholder approval for the issuance of common stock underlying the preferred stock and warrants.
• Acquiror must obtain conditional approval of its listing application from Nasdaq in connection with the Transactions.
• Acquiror will transfer its existing assets and liabilities to a newly established subsidiary (Legacy Sub) within 15 business days following the Closing.
• United Dogecoin (as Surviving Corporation) intends to secure a purchase order for up to 3,000 newest generation ElphaPex Mining Rigs.
• The mining rigs are expected to be online within 60 days of securing the purchase order.
• The company is obligated to file a registration statement covering the resale of Milestone Shares, Conversion Shares, and Warrant Shares within 15 days of receiving stockholder approval (or 45 days if the SEC reviews the statement).
• Acquiror will cause certain employees listed on Schedule 8.08 to execute employment agreements promptly following the Closing.

Key Dates

Recommendation

The filing details a complete pivot from a pharmaceutical software AI platform to Dogecoin mining, a highly speculative and volatile sector. This fundamental change in business model, coupled with massive dilution for existing shareholders (United Dogecoin holders will own 75.65% of the combined entity, or 68.85% fully diluted), fundamentally alters the investment thesis for Shuttle Pharmaceuticals. While the new management has experience in crypto, the inherent risks of cryptocurrency price volatility, regulatory uncertainty, and the unproven nature of a Dogecoin-specific mining strategy make this a high-risk proposition. The substantial fees paid to the placement agent further reduce the net capital available. For investors who bought into the original pharmaceutical business, this represents a forced exit into a completely different, high-risk venture with significant value erosion.

Keywords

Dogecoin mining, cryptocurrency, merger, PIPE financing, SHPH, United Dogecoin, blockchain, digital assets, Series B-1 Preferred Stock, Series B-2 Preferred Stock, pre-funded warrants, Nasdaq, ElphaPex Mining Rigs, hashrate, corporate governance, dilution